fat malabsorption

DBCOND0020593Digestive System DiseasesNutritional and Metabolic Diseases

fat malabsorption is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Steatorrhea · Steatorrhoea
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0003737SNOMED CT266481005MedDRA10016086UMLSC0038238

What you can answer from here — as of November 13, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for fat malabsorption share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In